SCHOTT KAISHA has launched a highly specialized glass syringe portfolio in India,that further minimizes the risk of drug/container interactions for sensitive drugs.As part of its German partner SCHOTTs iQ~TM platform,syriQBioPure~R is a hugely customizable glass prefillable staked-needle syringe (PFS)specifically designed to keep sensitive drugs stable over shelf life and shorten time to market while making administration more convenient for patients.Complex biotech drugs always face a threat of interacting with their container system.These interactions cannot be predicted and can lead to unintentional aggregation or deterioration of the drug which may eventually compromise the total cost of ownership,shelf life of the drug and treatment efficiency.
展开▼
